Genentech, Inc.


Genentech is a pioneering biotechnology company dedicated to groundbreaking science and developing medicines for serious and life-threatening diseases. As part of the Roche Group since 2009, it focuses on innovation in oncology, neuroscience, ophthalmology, and other areas, with a commitment to inclusive research, patient access, and societal impact.

Industries

biotechnology
life-science
manufacturing

Nr. of Employees

Very Large (1000+)

Genentech, Inc.

1 DNA Way, MS #35, South San Francisco, CA 94080


Patents

Production of proteins in glutamine-free cell culture media

US-12351641-B2

View Details

Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies

US-12351643-B2

View Details

Combination therapies

US-12354130-B2

View Details

Pyrido-pyrimidinone and pteridinone compounds and methods of use

US-12344603-B2

View Details

Bicyclic ketone compounds and methods of use thereof

US-12344612-B2

View Details

Bicyclic sulfones and sulfoxides and methods of use thereof

US-12338241-B2

View Details
View All Patents

Products

Commercial biologic medicines across multiple therapeutic areas

Commercialized and investigational biologic therapeutics for oncology, neuroscience, ophthalmology, respiratory, hematology, and rare diseases delivered through global commercialization and patient support channels.


Services

Programs to help patients access prescribed medicines, including patient assistance, co-pay assistance, and centralized access solutions.

Planning and conduct of clinical studies across therapeutic areas with programs to improve inclusive enrollment and study access.

Engagement with policymakers, state legislators, and payers to advocate for coverage of biomarker testing, precision medicine, and access policies.

Enterprise compliance functions including employee training, auditing and monitoring, incident investigation, corrective actions, and a 24/7 ethics hotline.

Expertise Areas

  • Clinical trial design and management
  • Biologic and antibody therapeutics development
  • Bioprocessing and manufacturing scale-up
  • Precision medicine and biomarker strategy
  • Show More (6)

Key Technologies

  • Therapeutic monoclonal antibody development
  • Recombinant DNA and biologics platforms
  • Biomarker assays (genetic and protein-based)
  • Next-generation diagnostics including liquid biopsy (implied)
  • Show More (4)

News & Updates

Glassdoor named Genentech one of the “Best Places to Work” in 2025.

Forbes named Genentech one of “America’s Best Large Employers” in 2025.

Genentech was named one of the “Best Workplaces for Commuters” in 2025.

Fast Company named Genentech one of its “Best Workplaces for Innovators” in 2024.

Computerworld named Genentech one of the “Best Places to Work in IT” in 2024.

Genentech was recognized as a finalist for Manufacturing Leadership Awards in 2024.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.